Blog
RSS FeedPosted by Michael Wonder on 02 Dec 2016
CADTH publishes final outcome for Darzalex (daratumumab)
1 December 2016 - The outcome relates to the use of daratumumab for the treatment of patients with multiple myeloma. ...
Posted by Michael Wonder on 02 Dec 2016
NICE recommends new lung cancer drug pembrolizumab
2 December 2016 - Hundreds of people with advanced lung cancer will now have access to new drug pembrolizumab, also known ...
Posted by Michael Wonder on 02 Dec 2016
ICER's final report on targeted immunomodulators for plaque psoriasis offers guidance for policy and practice
2 December 2016 - Independent CEPAC votes on value and subsequent policy roundtable discussion suggest that drug prices after rebates ...
Posted by Michael Wonder on 02 Dec 2016
FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes
2 December 2016 - The U.S. FDA today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular ...
Posted by Michael Wonder on 01 Dec 2016
CADTH publishes initial recommendation for Venclexta (venetoclax)
1 December 2016 - The outcome relates to the use of venetoclax for the treatment of patients with chronic lymphocytic ...
Posted by Michael Wonder on 01 Dec 2016
GSK gets green light to sell breakthrough asthma treatment to the NHS
1 December 2016 - GlaxoSmithKline has had one of its most promising new asthma drugs recommended for use on the ...
Posted by Michael Wonder on 30 Nov 2016
Curis announces full approval of Roche's Erivedge in the European Union
28 November 2016 - Curis today announced that the EMA CHMP has granted full approval to Erivedge (vismodegib) for the ...
Posted by Michael Wonder on 30 Nov 2016
Ariad announces FDA full approval and label update for Iclusig (ponatinib) based on long-term efficacy and safety data from Phase 2 PACE clinical trial
29 November 2016 - Full approval granted through completion of accelerated approval commitments for rare cancer patients who may have ...
Posted by Michael Wonder on 29 Nov 2016
NICE recommends 4p a day breast cancer drug
29 November 2016 - Women with a family history of breast cancer should be offered anastrozole, not tamoxifen, says NICE ...
Posted by Michael Wonder on 26 Nov 2016
Important new cancer treatments approved by Health Canada marred by major provincial reality disconnect for patients
22 November 2016 - Health Canada recently conditionally approved an advanced new treatment option for Canadians battling metastatic melanoma. ...
Posted by Michael Wonder on 25 Nov 2016
NICE reverses decision on CDF leukaemia drug after price drop
25 November 2016 - Hundreds of people could benefit as NICE decision means ibrutinib can come off the Cancer Drugs Fund ...
Posted by Michael Wonder on 25 Nov 2016
Ninlaro (ixazomib citrate) receives conditional approval from the European Commission to treat multiple myeloma
24 November 2016 - Approval based on TOURMALINE-MM1 study results, which demonstrated statistically significant six-month improvement in progression-free survival. ...
Posted by Michael Wonder on 24 Nov 2016
CADTH issues second final recommendation for Ibrance (palbociclib)
21 November 2016 - CADTH has published a final outcome for palbociclib following a resubmission from Pfizer. ...
Posted by Michael Wonder on 24 Nov 2016
Eli Lilly’s experimental Alzheimer’s drug fails in large trial
23 November 2016 - An experimental Alzheimer’s drug that had previously appeared to show promise in slowing the deterioration of ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves extended use of Harvoni
23 November 2016 - The TGÅ has approved the use of Harvoni in additional genotypes. ...